Editorial: Targeting cellular signalling pathways for disease therapy: the potential of cellular reprogramming and protein kinase inhibitors

Editorial: Targeting cellular signalling pathways for disease therapy: the potential of cellular reprogramming and protein kinase inhibitors

Saved in:

Bibliographic Details
Main Authors:	Vanessa Marensi, Pedro Fontes Oliveira, Ariane Zamoner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Pharmacology
Subjects:	cancer cell signal inhibitors cellular reprograming kinase inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1580686/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
by: Lucas Schoenfeldt, et al.
Published: (2025-06-01)

Genetic interaction profiles of regulatory kinases differ between environmental conditions and cellular states
by: Siyu Sun, et al.
Published: (2020-05-01)

Research progress on the effect of metabolic reprogramming on macrophage polarization
by: Jiangtao SHAO, et al.
Published: (2025-04-01)

Distinct cellular states determine calcium signaling response
by: Jason Yao, et al.
Published: (2016-12-01)

The role of macrophage metabolic reprogramming in myocardial infarction
by: ZOU Zicong, et al.
Published: (2024-11-01)

Cellular-compact and cellular-Lindelöf on hyperspaces
by: L.Q. Tuyen, et al.
Published: (2025-08-01)

Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC
by: Jiezhong Guan, et al.
Published: (2023-07-01)

The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer
by: Faris Alrumaihi, et al.
Published: (2025-06-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
by: Yaqi Zhou, et al.
Published: (2023-07-01)

Mathematical modeling of macrophage reprogramming during inflammation and immunity processes: obstacles and opportunities
by: V. N. Sakharov, et al.
Published: (2015-03-01)

Cellular Senescence: A Pathogenic Driver for Pulmonary Fibrosis
by: Sihan Wang, et al.
Published: (2025-06-01)

Simulation of earthquakes with cellular automata
by: P. G. Akishin, et al.
Published: (1998-01-01)

The crucial role of metabolic reprogramming in driving macrophage conversion in kidney disease
by: Na Gong, et al.
Published: (2025-06-01)

Function of MAP kinases in plant signal transduction pathway networks
by: SONG Dong-hui, et al.
Published: (2004-03-01)

Mechanism of Action of Exercise in Regulating Spontaneous Hypertension through the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway
by: Yu Li, et al.
Published: (2025-04-01)

Wireless In Situ Catalytic Electron Signaling‐Mediated Transcriptomic Reprogramming for Neuron Regeneration via Adaptable Antennas
by: Hoi Man Iao, et al.
Published: (2025-07-01)

Janus Kinase Inhibitors in the Treatment of Crohn’s Disease and Ulcerative Colitis: A Review
by: Olimpia Wiciun, et al.
Published: (2025-05-01)

Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect
by: O N. Kurochkina, et al.
Published: (2024-06-01)

An atlas of human kinase regulation
by: David Ochoa, et al.
Published: (2016-12-01)

Successful Treatment of Severe Nail Lichen Planus with Janus Kinase 1 Inhibitor Abrocitinib
by: Luo Y, et al.
Published: (2025-05-01)

The inhibitory effect of tyrosine kinase inhibitors on angiogenesis in zebrafish and interrelationship with the activation of the PI3K/AKT pathway
by: Lili Yang, et al.
Published: (2025-08-01)

Rejuvenated Autologous Adult Stem Cells: Emerging Front Runners in the Fight Against Aging and Associated Diseases
by: An Yu, et al.
Published: (2025-07-01)

Janus kinase inhibitors in the treatment of psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-02-01)

Prediction of in-hospital mortality in patients with myocardial infarction and type 2 diabetes: the role of cellular indices of systemic inflammation
by: I. F. Bokovikov, et al.
Published: (2024-08-01)

Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors
by: Sebastian Hüper, et al.
Published: (2025-07-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

The use of selective Janus kinase inhibitor upadacitinib in a patient with psoriatic arthritis (clinical observation)
by: Yu. A. Lushpaeva
Published: (2025-04-01)

Decidual natural killer cells and trophoblast cells: cellular, humoral and molecular mechanisms of interaction
by: P. V. Grebenkina, et al.
Published: (2022-12-01)

IQGAP scaffold proteins are the multifunctional regulators of cellular signaling and malignant transformation
by: P. A. Skovorodnikova, et al.
Published: (2017-07-01)

Food interactions with tyrosine kinase inhibitors used to treat advanced renal cell carcinoma
by: Agata Sałek-Zań, et al.
Published: (2025-03-01)

Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture
by: Erdinc Nayir, et al.
Published: (2017-07-01)

Epigenetic dysregulation-induced metabolic reprogramming fuels tumor progression in bladder cancer
by: Jian Zhang, et al.
Published: (2025-06-01)

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
by: V. A. Shuvaev, et al.
Published: (2014-07-01)

Division of a Natural Number by Two: A Cellular Automata-Based Approach
by: Mohammad Zeynali Azim, et al.
Published: (2025-01-01)

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension
by: Wenze Wu, et al.
Published: (2025-08-01)

ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies
by: Jixuan Zheng, et al.
Published: (2025-04-01)

Networking the nucleus
by: Indika Rajapakse, et al.
Published: (2010-07-01)

Tumor Necrosis Factor-α Induced Cellular Stress on Trophoblastic Cells: NF-κB Signaling Could be a Potential Therapeutic Target
by: Erengül Tokay Varolli, et al.
Published: (2021-06-01)

miR-200b regulates cellular senescence and inflammatory responses by targeting ZEB2 in pulmonary emphysema
by: Zhiming Shen, et al.
Published: (2020-01-01)

FDA-approved kinase inhibitors in PROTAC design, development and synthesis
by: Kacper Kossakowski, et al.
Published: (2025-12-01)